JP2017525712A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017525712A5 JP2017525712A5 JP2017510539A JP2017510539A JP2017525712A5 JP 2017525712 A5 JP2017525712 A5 JP 2017525712A5 JP 2017510539 A JP2017510539 A JP 2017510539A JP 2017510539 A JP2017510539 A JP 2017510539A JP 2017525712 A5 JP2017525712 A5 JP 2017525712A5
- Authority
- JP
- Japan
- Prior art keywords
- tablet
- contained
- range
- tablet according
- azepino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462040849P | 2014-08-22 | 2014-08-22 | |
| US62/040,849 | 2014-08-22 | ||
| US201562101739P | 2015-01-09 | 2015-01-09 | |
| US62/101,739 | 2015-01-09 | ||
| PCT/US2015/045522 WO2016028689A1 (en) | 2014-08-22 | 2015-08-17 | High dosage strength tablets of rucaparib |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019149084A Division JP6797980B2 (ja) | 2014-08-22 | 2019-08-15 | ルカパリブの高投与力価錠剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017525712A JP2017525712A (ja) | 2017-09-07 |
| JP2017525712A5 true JP2017525712A5 (enExample) | 2018-09-27 |
| JP6574477B2 JP6574477B2 (ja) | 2019-09-11 |
Family
ID=55347324
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017510539A Active JP6574477B2 (ja) | 2014-08-22 | 2015-08-17 | ルカパリブの高投与力価錠剤 |
| JP2019149084A Active JP6797980B2 (ja) | 2014-08-22 | 2019-08-15 | ルカパリブの高投与力価錠剤 |
| JP2020191356A Active JP7127101B2 (ja) | 2014-08-22 | 2020-11-18 | ルカパリブの高投与力価錠剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019149084A Active JP6797980B2 (ja) | 2014-08-22 | 2019-08-15 | ルカパリブの高投与力価錠剤 |
| JP2020191356A Active JP7127101B2 (ja) | 2014-08-22 | 2020-11-18 | ルカパリブの高投与力価錠剤 |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US9987285B2 (enExample) |
| EP (1) | EP3182975B1 (enExample) |
| JP (3) | JP6574477B2 (enExample) |
| KR (2) | KR20170043597A (enExample) |
| CN (2) | CN106794185A (enExample) |
| AU (2) | AU2015305696B2 (enExample) |
| BR (1) | BR112017000865A2 (enExample) |
| CA (1) | CA2955495C (enExample) |
| DK (1) | DK3182975T3 (enExample) |
| ES (1) | ES3048688T3 (enExample) |
| FI (1) | FI3182975T3 (enExample) |
| HR (1) | HRP20251484T1 (enExample) |
| IL (1) | IL249946B (enExample) |
| LT (1) | LT3182975T (enExample) |
| MX (1) | MX367260B (enExample) |
| NZ (1) | NZ728392A (enExample) |
| PL (1) | PL3182975T3 (enExample) |
| PT (1) | PT3182975T (enExample) |
| RS (1) | RS67356B1 (enExample) |
| RU (1) | RU2705156C2 (enExample) |
| SG (1) | SG11201700265VA (enExample) |
| SI (1) | SI3182975T1 (enExample) |
| WO (1) | WO2016028689A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12168004B2 (en) | 2014-02-05 | 2024-12-17 | Merck Sharp & Dohme Llc | Treatment of migraine |
| HK1232218A1 (zh) | 2014-02-05 | 2018-01-05 | Merck Sharp & Dohme Llc | Cgrp-活性化合物的片剂制剂 |
| DK3182975T3 (da) * | 2014-08-22 | 2025-10-20 | Pharma& Schweiz Gmbh | Tabletter med høj doseringsstyrke af rucaparib |
| CN106008530B (zh) * | 2016-07-24 | 2018-06-26 | 石家庄久正生物科技有限公司 | 一种抗卵巢癌药物Rucaparib关键中间体的制备方法 |
| CN108201534A (zh) * | 2016-12-16 | 2018-06-26 | 苏州苏融生物医药有限公司 | 一种瑞卡帕布口服缓控释药物组合物及其用途 |
| ES2985767T3 (es) | 2017-01-24 | 2024-11-07 | Assia Chem Ind Ltd | Formas en estado sólido de rucaparib y de sales de rucaparib |
| EP3600314A1 (en) | 2017-03-27 | 2020-02-05 | Tesaro, Inc. | Niraparib compositions |
| CA3076907A1 (en) | 2017-09-26 | 2019-04-04 | Tesaro, Inc. | Niraparib formulations |
| WO2019130229A1 (en) | 2017-12-28 | 2019-07-04 | Mylan Laboratories Ltd | Methods and intermediates for preparing rucaparib |
| KR20200121800A (ko) | 2018-01-05 | 2020-10-26 | 싸이브렉사 1, 인크. | 산성 또는 저산소성 질환에 걸린 조직에 관련된 질환의 치료를 위한 화합물, 조성물 및 방법 |
| US12383545B1 (en) | 2018-06-08 | 2025-08-12 | Allergan Pharmaceuticals International Limited | Treatment of migraine |
| US12090148B2 (en) | 2020-07-29 | 2024-09-17 | Allergan Pharmaceuticals International Limited | Treatment of migraine |
| CN109111454A (zh) * | 2018-08-01 | 2019-01-01 | 宁波金未生物科技有限公司 | 一种瑞卡帕布s-樟脑磺酸盐 |
| CN108853030B (zh) * | 2018-09-26 | 2021-10-01 | 上海朝晖药业有限公司 | 一种治疗恶性肿瘤的药物制剂及其制备方法 |
| CN111542527A (zh) * | 2018-12-06 | 2020-08-14 | 上海诚妙医药科技有限公司 | 芦卡帕利樟脑磺酸盐的新晶型和制备方法及其用途 |
| MY209459A (en) | 2019-07-10 | 2025-07-09 | Cybrexa 3 Inc | Peptide conjugates of microtubule-targeting agents as therapeutics |
| CA3146560A1 (en) | 2019-07-10 | 2021-01-14 | Cybrexa 2, Inc. | Peptide conjugates of cytotoxins as therapeutics |
| KR20230002487A (ko) | 2020-04-28 | 2023-01-05 | 리젠 파마슈티컬스 아게 | 폴리(adp-리보스) 폴리머라제(parp) 억제제로서 유용한 신규 화합물 |
| HRP20251324T1 (hr) | 2020-07-14 | 2025-12-05 | Assia Chemical Industries Ltd. | Oblici soli rukapariba u krutom stanju |
| WO2022090938A1 (en) | 2020-10-31 | 2022-05-05 | Rhizen Pharmaceuticals Ag | Phthalazinone derivatives useful as parp inhibitors |
| WO2022140537A1 (en) | 2020-12-22 | 2022-06-30 | Allergan Pharmaceuticals International Limited | Treatment of migraine |
| BR112023020615A2 (pt) | 2021-04-08 | 2023-12-19 | Incozen Therapeutics Pvt Ltd | Inibidores de poli(adp-ribose) polimerase |
| AU2022353124A1 (en) | 2021-09-27 | 2024-04-11 | Allergan Pharmaceuticals International Limited | Combination comprising atogepant for treating migraine |
| US11738029B2 (en) * | 2021-11-10 | 2023-08-29 | Crititech, Inc. | Rucaparib particles and uses thereof |
| US20250223295A1 (en) | 2022-01-11 | 2025-07-10 | Assia Chemical Industries Ltd. | Solid state forms of rucaparib tosylate |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20010573B1 (en) | 1999-01-11 | 2006-04-30 | Agouron Pharmaceuticals | Tricyclic inhibitors of poly(adp-ribose) polymerases |
| CA2520997A1 (en) | 2003-03-31 | 2004-10-14 | Stacie Sara Canan-Koch | Salts of tricyclic inhibitors of poly(adp-ribose) polymerases |
| ATE454893T1 (de) | 2003-07-25 | 2010-01-15 | Cancer Rec Tech Ltd | Tricyclische parp-hemmer |
| JP2008513436A (ja) | 2004-09-22 | 2008-05-01 | ファイザー・インク | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンのリン酸塩の多形性及び非晶質形態 |
| PL1794163T3 (pl) | 2004-09-22 | 2010-06-30 | Pfizer | Sposób wytwarzania inhibitorów poli(adp-rybozo)polimerazy |
| JP2008513435A (ja) | 2004-09-22 | 2008-05-01 | ファイザー・インク | ポリ（ａｄｐ−リボース）ポリメラーゼ阻害剤を含む治療用組成物 |
| CA2720744A1 (en) * | 2008-04-09 | 2009-10-15 | Lek Pharmaceuticals D.D. | Granulation of active pharmaceutical ingredients |
| RS55487B2 (sr) | 2010-02-12 | 2024-06-28 | Pfizer | Soli i polimorfi 8-fluoro-2-{4-[(metilamino}metil]fenil}-1,3,4,5-tetrahidro-6h-azepino[5,4,3-cd]indol-6-ona |
| PT2833973T (pt) | 2012-04-05 | 2017-12-21 | Vertex Pharma | Compostos úteis como inibidores da cinase atr e terapias de combinação dos mesmos |
| DK3182975T3 (da) | 2014-08-22 | 2025-10-20 | Pharma& Schweiz Gmbh | Tabletter med høj doseringsstyrke af rucaparib |
-
2015
- 2015-08-17 DK DK15833096.9T patent/DK3182975T3/da active
- 2015-08-17 HR HRP20251484TT patent/HRP20251484T1/hr unknown
- 2015-08-17 SG SG11201700265VA patent/SG11201700265VA/en unknown
- 2015-08-17 SI SI201532081T patent/SI3182975T1/sl unknown
- 2015-08-17 NZ NZ728392A patent/NZ728392A/en unknown
- 2015-08-17 CA CA2955495A patent/CA2955495C/en active Active
- 2015-08-17 PT PT158330969T patent/PT3182975T/pt unknown
- 2015-08-17 CN CN201580042815.9A patent/CN106794185A/zh active Pending
- 2015-08-17 ES ES15833096T patent/ES3048688T3/es active Active
- 2015-08-17 AU AU2015305696A patent/AU2015305696B2/en active Active
- 2015-08-17 EP EP15833096.9A patent/EP3182975B1/en active Active
- 2015-08-17 KR KR1020177007284A patent/KR20170043597A/ko not_active Ceased
- 2015-08-17 KR KR1020237020594A patent/KR102803917B1/ko active Active
- 2015-08-17 LT LTEPPCT/US2015/045522T patent/LT3182975T/lt unknown
- 2015-08-17 MX MX2017001540A patent/MX367260B/es active IP Right Grant
- 2015-08-17 BR BR112017000865A patent/BR112017000865A2/pt not_active Application Discontinuation
- 2015-08-17 PL PL15833096.9T patent/PL3182975T3/pl unknown
- 2015-08-17 WO PCT/US2015/045522 patent/WO2016028689A1/en not_active Ceased
- 2015-08-17 FI FIEP15833096.9T patent/FI3182975T3/fi active
- 2015-08-17 US US14/828,065 patent/US9987285B2/en active Active
- 2015-08-17 RU RU2017109139A patent/RU2705156C2/ru active
- 2015-08-17 JP JP2017510539A patent/JP6574477B2/ja active Active
- 2015-08-17 RS RS20251082A patent/RS67356B1/sr unknown
- 2015-08-17 CN CN202110458329.2A patent/CN113209033A/zh active Pending
-
2017
- 2017-01-05 IL IL249946A patent/IL249946B/en active IP Right Grant
-
2018
- 2018-03-14 US US15/920,643 patent/US10130636B2/en active Active
- 2018-10-08 US US16/154,038 patent/US20190099430A1/en not_active Abandoned
-
2019
- 2019-08-15 JP JP2019149084A patent/JP6797980B2/ja active Active
- 2019-11-29 AU AU2019272064A patent/AU2019272064B2/en active Active
-
2020
- 2020-11-18 JP JP2020191356A patent/JP7127101B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017525712A5 (enExample) | ||
| RU2017109139A (ru) | Таблетки, содержащие большую дозу рукапариба | |
| TWI583384B (zh) | 包含４－胺基－５－氟－３－［６－（４－甲基哌嗪－１－基）－１ｈ－苯并咪唑－２－基］－１ｈ－喹啉－２－酮乳酸鹽單水合物之醫藥組合物 | |
| JP7023945B2 (ja) | レナリドミドの経口用錠剤組成物 | |
| JP6245677B2 (ja) | 口腔内崩壊錠 | |
| JP2011098964A5 (enExample) | ||
| ES2311442T1 (es) | Dosis en forma oral. | |
| CN104661649A (zh) | 包含替格瑞洛的固态口服医药制剂 | |
| WO2013084089A1 (en) | Methods for treating cardiovascular disorder | |
| WO2015029074A2 (en) | Compositions of eltrombopag | |
| JP2015521191A5 (enExample) | ||
| CN101478966B (zh) | 压缩制剂 | |
| CA2764172A1 (en) | A thrombin receptor antagonist and clopidogrel fixed dose tablet | |
| JP2005538097A (ja) | Ｈｍｇ−ｃｏａレダクターゼインヒビターを含む組成物 | |
| CN101312714A (zh) | 替米沙坦的药用组合物 | |
| KR20180083239A (ko) | 리마프로스트 또는 리마프로스트 알파엑스를 함유한 경구용 서방성 제제 조성물 | |
| CA2833115C (en) | Pharmaceutical compositions of raltegravir, methods of preparation and use thereof | |
| AU2016231883B2 (en) | Pharmaceutical compositions of dimethyl fumarate | |
| WO2014058047A1 (ja) | カルシウム拮抗薬／アンジオテンシンｉｉ受容体拮抗薬含有医薬製剤の製造方法 | |
| WO2011080706A1 (en) | Enhanced solubility of ziprasidone | |
| KR20100083047A (ko) | 생체이용률이 향상된 발사르탄을 포함하는 약제학적 조성물 | |
| WO2016012898A1 (en) | Oral pharmaceutical composition of lurasidone | |
| JP2016539109A (ja) | イソニアジドの顆粒およびリファペンチンの顆粒を含むコーティング錠の形態の抗結核性の安定な医薬組成物ならびにその製造方法 | |
| JP5241511B2 (ja) | 溶出性の改善された医薬組成物 | |
| JP2007512287A5 (enExample) |